Companies Dominating the Clostridium Diagnostics Market
- Cerebriu
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Diazyme Laboratories, Inc.
- BioMerieux
- Beckman Coulter, Inc.
- F. Hoffmann-La Roche
- Chrono-log Corporation
- Hikma Pharmaceutical PLC
- Pfizer Inc.
- Baxter
- DiaSorin SpA
Browse Key Market Insights with Data Illustration:
In the News
- Cerebriu, a company that offers artificial intelligence (AI) solutions for streamlining radiology processes, and Siemens Healthineers, the top producer of magnetic resonance imaging (MRI) scanners worldwide, have partnered to incorporate Cerebriu's unique Smart ProtocolTM for Brain MRI-workflow automation software into Siemens Healthineers' MRI equipment.
- Diazyme Laboratories and Maccura Biotechnology announced a collaboration to launch an FDA EUA-approved SARS-COV-2 RT-PCR diagnostic test. Located in Poway, California, Diazyme Laboratories Inc. is a Life Science Affiliate of General Atomics. Using its patented enzyme and immunoassay technology, Diazyme creates user-friendly diagnostic test reagents that may be used with automated chemistry analyzers and chemiluminescence equipment.
